CoChat

Approach to the Patient: Diagnosis of Cushing Syndrome

Open access
Savas, Mesut, Mehta, Sonal, Agrawal, Nidhi, van Rossum, Elisabeth F C, Feelders, Richard A · 2022 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 96 of the 100 references it cites were found in a registry or an index; 50 of the 202 sources its claims cite were checked for support.

Abstract

Cushing syndrome results from supraphysiological exposure to glucocorticoids and is associated with significant morbidity and mortality. The pathogenesis includes administration of corticosteroids (exogenous Cushing syndrome) or autonomous cortisol overproduction, whether or not ACTH-dependent (endogenous Cushing syndrome). An early diagnosis of Cushing syndrome is warranted; however, in clinical practice, it is very challenging partly because of resemblance with other common conditions (ie, pseudo-Cushing syndrome). Initial workup should start with excluding local and systemic corticosteroid use. First-line screening tests including the 1-mg dexamethasone suppression test, 24-hour urinary free cortisol excretion, and late-night salivary cortisol measurement should be performed to screen for endogenous Cushing syndrome. Scalp-hair cortisol/cortisone analysis helps in the assessment of long-term glucocorticoid exposure as well as in detection of transient periods of hypercortisolism as observed in cyclical Cushing syndrome. Interpretation of results can be difficult because of individual patient characteristics and hence requires awareness of test limitations. Once endogenous Cushing syndrome is established, measurement of plasma ACTH concentrations differentiates between ACTH-dependent (80%-85%) or ACTH-independent (15%-20%) causes. Further assessment with different imaging modalities and dynamic biochemical testing including bilateral inferior petrosal sinus sampling helps further pinpoint the cause of Cushing's syndrome. In this issue of "Approach to the patient," the diagnostic workup of Cushing syndrome is discussed with answering the questions when to screen, how to screen, and how to differentiate the different causes. In this respect, the latest developments in biochemical and imaging techniques are discussed as well.

Overview

CoChat Summary

## TL;DR

This article is a clinical review of how to diagnose Cushing syndrome, emphasizing when to screen, how to interpret first-line tests, and how to distinguish pseudo-Cushing, ACTH-dependent, ACTH-independent, and pregnancy-related cases. It uses two cases to illustrate common diagnostic pitfalls, including anticonvulsant interference with dexamethasone testing and intermediate ACTH values that require additional biochemical and imaging workup.

## Key findings

  • Cushing syndrome is associated with serious morbidity and mortality; the paper states a 3.5 to 5 times increased mortality risk versus the general population, and the risk of myocardial infarction is about 4.5 times higher.
  • Endogenous Cushing syndrome is estimated to have an incidence of 0.2 to 5.0 per million people per year and a prevalence of 39 to 79 per million; 80% to 85% of cases are ACTH-dependent and 15% to 20% are ACTH-independent.
  • First-line screening tests recommended are 1-mg dexamethasone suppression test (DST), 24-hour urinary free cortisol (UFC), and late-night salivary cortisol (LNSC); UFC and LNSC should be done at least twice because of day-to-day variation.
  • In the hair-cortisol section, the paper reports hair cortisone had 87% sensitivity and 90% specificity, compared with hair cortisol at 81% sensitivity and 88% specificity, for distinguishing Cushing syndrome in the cited studies.

## Methods

  • This is an expert clinical review in the “Approach to the Patient” format, organized around diagnostic questions: when to screen, how to screen, and how to differentiate causes of Cushing syndrome.
  • The paper draws on two illustrative cases: case 1 involved a 45-year-old woman with suspected pseudo-Cushing syndrome and case 2 a 52-year-old woman with adrenal imaging findings, venous thrombosis, and ultimately pituitary-dependent Cushing syndrome.
  • The main analysis is a narrative synthesis of diagnostic strategies using biochemical tests (DST, UFC, LNSC, ACTH, DHEAS, CRH testing, dexamethasone-CRH testing), imaging (pituitary MRI, adrenal CT/MRI, PET), and bilateral inferior petrosal sinus sampling.

## Limitations

  • The paper states that all tests have caveats and interpretation requires awareness of individual patient characteristics and test limitations.
  • It explicitly notes that the hair cortisol/cortisone method is not yet widely available and is still a relatively novel diagnostic tool.
  • Evident from the text: this is a review with illustrative cases, not a primary diagnostic accuracy study of all recommended tests, so some performance figures are drawn from cited prior studies rather than generated directly in this paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgac492

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Clinical features and comorbidities associated with Cushing syndrome. Based on Agrawal et al (1), Sharma et al (5), and Pivonello et al (27).
Figure 1. Clinical features and comorbidities associated with Cushing syndrome. Based on Agrawal et al (1), Sharma et al (5), and Pivonello et al (27).CC BY-NC-ND · PubMed Central
Figure 2. Diagnostic workup of Cushing syndrome. Flowchart is based on Lacroix et al (3). The likelihood ratios (LRs) for the first-line screening tests and scalp hair analysis concern pooled data from (47) and findings from (48), respectively. LRs take sensitivity and specificity into account and determine the posttest probability given a certain pretest probability (higher LR+ = increasing probability of disease with positive test result; lower LR- = decreasing probability of disease with negative test result). Abbreviations: CBG, cortisol-binding globulin; LR-, negative likelihood ratio; LR+, positive likelihood ratio.
Figure 2. Diagnostic workup of Cushing syndrome. Flowchart is based on Lacroix et al (3). The likelihood ratios (LRs) for the first-line screening tests and scalp hair analysis concern pooled data from (47) and findings from (48), respectively. LRs take sensitivity and specificity into account and determine the posttest probability given a certain pretest probability (higher LR+ = increasing probability of disease with positive test result; lower LR- = decreasing probability of disease with negative test result). Abbreviations: CBG, cortisol-binding globulin; LR-, negative likelihood ratio; LR+, positive likelihood ratio.CC BY-NC-ND · PubMed Central
Figure 3. Sources of ectopic ACTH secretion. Based on Lacroix et al (2).
Figure 3. Sources of ectopic ACTH secretion. Based on Lacroix et al (2).CC BY-NC-ND · PubMed Central
Figure 4. (Patho)physiologic changes of hypothalamus-pituitary-adrenal axis during pregnancy. Based on Brue et al (90). Abbreviation: CRH, corticotropin-releasing hormone.
Figure 4. (Patho)physiologic changes of hypothalamus-pituitary-adrenal axis during pregnancy. Based on Brue et al (90). Abbreviation: CRH, corticotropin-releasing hormone.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

39 Valid · 2 Not valid · 70 Not checked · 18 Own results and interpretations

76 more claims · 24 with their cited sources checked

Create a free account to see all 129 claims and to verify the 46 references still open.

See all claims — free account
  • It may state two separate claims as one. 39
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Citations

Cites

Show all 96 references

Research works printed but not linked: 1

  1. Agrawal, 2021, The Human Hypothalamus, 185

Cited by

See all 91

Metadata

Authors
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A.
Affiliations
  • Erasmus MC (NL)
  • NYU Langone Health (US)
  • Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2022-08-29
Volume
107
Issue
11
Pages
3162-3174
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4293457641
Cited by
91
References
100
Citations by year
2026: 25 · 2025: 35 · 2024: 17 · 2023: 12 · 2022: 2
FWCI
12.22
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords
Cushing's syndrome, endogenous Cushing syndrome, dexamethasone suppression test, 24-hour urinary free cortisol, late-night salivary cortisol, ACTH-dependent Cushing's syndrome, ACTH-independent Cushing's syndrome, plasma ACTH, inferior petrosal sinus sampling, hypercortisolism
MeSH terms
Cushing Syndrome, Diagnosis, Differential, Glucocorticoids, Humans, Hydrocortisone, Petrosal Sinus Sampling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Approach to the Patient: Diagnosis of Cushing Syndrome. https://app.cochat.ai/papers/10.1210/clinem/dgac492
The paper
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022). Approach to the Patient: Diagnosis of Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac492

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.